Please assess the completion status of the following clinical trial:

Trial Title: Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* at least 18 years of age~* current diagnosis of primary body dysmorphic disorder (BDD), based on a clinical structured diagnostic interview~* currently living in the United States~Exclusion Criteria:~* Psychotropic medication changes within 2 months prior to enrollment (Participants taking psychotropic medication must have been on a stable dose for at least 2 months prior to enrollment and not change medication during study period)~* Past participation in 4+ sessions of cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD)~* Current severe substance use disorder~* Lifetime bipolar disorder or psychosis~* Acute, active suicidal ideation as indicated by clinical judgment and/or a score \>2 on the suicidal ideation subscale of the Columbia-Suicide Severity Rating Scale (C-SSRS).~* Current severe comorbid major depression, as indicated by clinical judgment and/or a Quick Inventory of Depressive Symptomatology- Self Report (QIDS-SR) total score ≥ 21~* Concurrent psychological treatment~* Does not own a supported Smartphone with a data plan~* Lack of technology literacy that would interfere with ability to engage with smartphone treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Smartphone-delivered cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD) (Type: EXPERIMENTAL): 12-week Smartphone-delivered CBT for BDD.
- 12 Week Waitlist Control (Type: OTHER): 12 week waitlist control. (Note: participants will be crossed over to 12-week Smartphone-delivered CBT for BDD following the 12-week waitlist control).

Based on this trial design, predict the completion outcome and termination type (if applicable).